Active Hexose Correlated Compound clinical trials
Also written AHCC.
How each study uses Active Hexose Correlated Compound is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Active Hexose Correlated Compound studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- AHCC
- 2
Studies by the year they started
4 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
University of California, Davis (1) · University of Nottingham (1) · Hasanuddin University (1) · National Cheng-Kung University Hospital (1)
Often tested with
Tested in the same studies.
Bifidobacterium longum BB536 (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Active Hexose Correlated Compound.
- Dec 2026Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant ChemotherapyPhase 2 · University of California, Davis
- Feb 2027Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years OldPhase 4 · Hasanuddin University
Studies
Open first, then newest update. How each study uses Active Hexose Correlated Compound is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years OldNot yet recruitingPhase 4Hasanuddin UniversityNCT07479394Written as a prebiotic, that us a standardized extract of cultured Lentinula edodes myceliaHow we know
- AHCC® as Immune Modulator in Cancer Patients Treated With ImmunotherapyNot yet recruitingNot applicableNational Cheng-Kung University HospitalNCT07118735Written as A standardized extract of cultured Lentinula edodes mycelia (AHCC®)How we know
- Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant ChemotherapyActive, not recruitingPhase 2University of California, DavisNCT05763199Written as AHCCHow we know
- Biological Modulation of Bacterial QSSMs, Innate and Adaptive Immunity by Antibiotics, Probiotics and Prebiotics in Healthy IndividualsCompletedPhase 1University of NottinghamNCT01201577Written as Active hexose correlated compound (AHCC)How we know
Codes
What other systems call Active Hexose Correlated Compound · ClinicalTrials.gg INT004756
- MeSH (NLM) C499366Active Hexose Correlated CompoundOne source NLM
- UNII (FDA) S1W5KTD68YACTIVE HEXOSE CORRELATED COMPOUNDConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C499366 | Active Hexose Correlated Compound | One source NLM |
| UNII (FDA) | S1W5KTD68Y | ACTIVE HEXOSE CORRELATED COMPOUND | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.